BioPharma Credit PLC
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
BioPharma Credit PLC (BOPCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.029x
Based on the latest financial reports, BioPharma Credit PLC (BOPCF) has a cash flow conversion efficiency ratio of 0.029x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($33.76 Million) by net assets ($1.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioPharma Credit PLC - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how BioPharma Credit PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioPharma Credit PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioPharma Credit PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
COAST.FINL. CORP.WA NEW
F:1VD
|
N/A |
|
CORDIANT DIGITAL INFRAST.
F:86L
|
N/A |
|
Bajaj Housing Finance
NSE:BAJAJHFL
|
-0.162x |
|
Raven Industries Inc
F:RV1
|
0.006x |
|
Elders Ltd
AU:ELD
|
0.080x |
|
Cadeler As
OL:CADLR
|
0.148x |
|
UNITIL Corporation
NYSE:UTL
|
0.026x |
|
Bright Smart Securities & Commodities Group Limited
F:0BX
|
-0.011x |
Annual Cash Flow Conversion Efficiency for BioPharma Credit PLC (2017–2024)
The table below shows the annual cash flow conversion efficiency of BioPharma Credit PLC from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.18 Billion | $111.91 Million | 0.095x | +3.09% |
| 2023-12-31 | $1.34 Billion | $123.18 Million | 0.092x | -33.31% |
| 2022-12-31 | $1.34 Billion | $184.28 Million | 0.138x | +94.80% |
| 2021-12-31 | $1.36 Billion | $96.44 Million | 0.071x | +67.91% |
| 2020-12-31 | $1.38 Billion | $58.07 Million | 0.042x | -55.05% |
| 2019-12-31 | $1.40 Billion | $131.52 Million | 0.094x | +92.59% |
| 2018-12-31 | $1.38 Billion | $67.14 Million | 0.049x | +94.57% |
| 2017-12-31 | $922.57 Million | $23.07 Million | 0.025x | -- |